Given that Smpd3 DNA methylation controls transcription activity in both liver and adipose tissues during the pathogenesis of NAFLD, the excellent concordance between GEO analysis and our mouse data further suggests that the DNA methylation profile of Smpd3 seen in NASH and mild fibrosis is robust. The gene discussed is SMPD3; the disease is metabolic dysfunction-associated steatotic liver disease.